Applied Dna Sciences Inc [NASDAQ: APDN] stock went on an upward path that rose over 78.22% on Friday, amounting to a one-week price increase of more than 117.47%.
Over the last 12 months, APDN stock dropped by -97.39%. The one-year Applied Dna Sciences Inc stock forecast points to a potential upside of 48.0. The average equity rating for APDN stock is currently 2.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $8.06 million, with 10.30 million shares outstanding and 10.18 million shares in the current float. Compared to the average trading volume of 1.54M shares, APDN stock reached a trading volume of 49945525 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Applied Dna Sciences Inc [APDN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APDN shares is $1.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APDN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH Capital have made an estimate for Applied Dna Sciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 12, 2021. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $18 to $14. The new note on the price target was released on January 14, 2021, representing the official price target for Applied Dna Sciences Inc stock. Previously, the target price had yet another drop from $20 to $12, while H.C. Wainwright kept a Buy rating on APDN stock. On July 20, 2020, analysts increased their price target for APDN shares from 18 to 22.
The Average True Range (ATR) for Applied Dna Sciences Inc is set at 0.10, with the Price to Sales ratio for APDN stock in the period of the last 12 months amounting to 2.37. The Price to Book ratio for the last quarter was 0.65, with the Price to Cash per share for the same quarter was set at 1.01.
APDN Stock Performance Analysis:
Applied Dna Sciences Inc [APDN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 117.47. With this latest performance, APDN shares gained by 91.23% in over the last four-week period, additionally sinking by -93.54% over the last 6 months – not to mention a drop of -97.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APDN stock in for the last two-week period is set at 74.39, with the RSI for the last a single of trading hit 87.76, and the three-weeks RSI is set at 55.78 for Applied Dna Sciences Inc [APDN]. The present Moving Average for the last 50 days of trading for this stock 0.4404, while it was recorded at 0.4763 for the last single week of trading, and 8.0222 for the last 200 days.
Insight into Applied Dna Sciences Inc Fundamentals:
Applied Dna Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.76 and a Current Ratio set at 3.91.
APDN Stock EPS
With the latest financial reports released by the company, Applied Dna Sciences Inc posted -5.2/share EPS, while the average EPS was predicted by analysts to be reported at -5.4/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.2. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APDN.
Applied Dna Sciences Inc [APDN] Institutonal Ownership Details
The top three institutional holders of APDN stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in APDN stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in APDN stock with ownership which is approximately 5.1238%.
